Pharmacokinetics and disposition of dalcetrapib in rats and monkeys

Effect of Hepatic and Renal Impairment on the Pharmacokinetics of Dalcetrapib

(2013) Mary Phelan et al.   CLINICAL PHARMACOKINETICS

Solubility and stability of dalcetrapib in vehicles and biological media

(2012) Günter Gross et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Evidence of a Drug–Drug Interaction Linked to Inhibition of Ester Hydrolysis by Orlistat

(2012) Darren Bentley et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Determination of dalcetrapib by liquid chromatography–tandem mass spectrometry

(2012) Katja Heinig et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

(2012) Gregory G. Schwartz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dalcetrapib pharmacokinetics and metabolism in the cynomolgus monkey

(2011) Olaf Kuhlmann et al.   XENOBIOTICA

A single-center, open-label, one-sequence study of dalcetrapib coadministered with ketoconazole, and an in vitro study of the S-methyl metabolite of dalcetrapib

(2009) Michael Derks et al.   CLINICAL THERAPEUTICS